Uta Griesenbach is a Professor in Molecular Medicine at the National Heart and Lung Institute, Imperial College London and the President of the British Society for Gene and Cell Therapy (www.bsgct.org/). Uta‘s reserach interests are related to the development of gene therapy-based treatments for cystic fibrosis and other inflammatory lung diseases and include vector and biomarker development, toxicology and safety as well as GMP-vector production. Uta is Co-Investigator on several gene therapy trials, including a recently completed non-viral Phase IIb study. Uta is a Strategy Group Member of the UK Cystic Fibrosis Gene Therapy Consortium (www.cfgenetherapy.org.uk/) and is the Gene Therapy advisor (GTAC) on the West London National Research Ethics Comittee. In addition, Uta is interested in teaching and work-force development. She is Deputy-director for post-graduate reserach at the National Heart and Lung Institute and Programme director for the MSc in Genes, Drugs and Stem cells-Novel Therapies at Imperial College.
There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.
There is a registration fee to attend the conferences. To visit the exhibition is free.